Fisher Asset Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7,459
| Closed | -$956K | – | 1020 |
|
|
2025
Q2 | $956K | Sell |
7,459
-303,275
| -98% | -$31.5M | ﹤0.01% | 698 |
|
|
2025
Q1 | $27.5M | Sell |
310,734
-12,306
| -4% | -$1.2M | 0.01% | 283 |
|
|
2024
Q4 | $28.2M | Sell |
323,040
-12,310
| -4% | -$1.13M | 0.01% | 301 |
|
|
2024
Q3 | $31M | Sell |
335,350
-815
| -0.2% | -$81K | 0.01% | 288 |
|
|
2024
Q2 | $36.2M | Buy |
336,165
+1,037
| +0.3% | +$104K | 0.02% | 262 |
|
|
2024
Q1 | $31.8M | Buy |
335,128
+8,464
| +3% | +$726K | 0.01% | 274 |
|
|
2023
Q4 | $30.1M | Sell |
326,664
-55,249
| -14% | -$3.58M | 0.02% | 276 |
|
|
2023
Q3 | $19.2M | Sell |
381,913
-417,468
| -52% | -$22.3M | 0.01% | 358 |
|
|
2023
Q2 | $50.5M | Buy |
799,381
+5,310
| +0.7% | +$289K | 0.03% | 247 |
|
|
2023
Q1 | $35.7M | Sell |
794,071
-49,019
| -6% | -$2.21M | 0.02% | 289 |
|
|
2022
Q4 | $36.9M | Buy |
843,090
+117,553
| +16% | +$5.64M | 0.03% | 279 |
|
|
2022
Q3 | $47.8M | Buy |
725,537
+155,026
| +27% | +$9.96M | 0.04% | 237 |
|
|
2022
Q2 | $28.8M | Buy |
570,511
+172,456
| +43% | +$10.1M | 0.02% | 276 |
|
|
2022
Q1 | $25.4M | Sell |
398,055
-2,218
| -0.6% | -$159K | 0.02% | 299 |
|
|
2021
Q4 | $42.9M | Buy |
400,273
+84,615
| +27% | +$8.85M | 0.02% | 262 |
|
|
2021
Q3 | $32.5M | Buy |
+315,658
| New | +$29.4M | 0.02% | 269 |
|
Other funds holding BPMC
IA
HNB